近岸蛋白
(688137)
| 流通市值：10.87亿 | | | 总市值：23.35亿 |
| 流通股本：3267.54万 | | | 总股本：7017.54万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 33,444,619.29 | 127,555,134.78 | 92,079,068.48 | 59,655,247.04 |
| 营业收入 | 33,444,619.29 | 127,555,134.78 | 92,079,068.48 | 59,655,247.04 |
| 二、营业总成本 | 41,376,150.08 | 166,495,773.97 | 115,556,413.23 | 76,651,133.2 |
| 营业成本 | 12,622,698.28 | 47,989,594.78 | 32,652,717.32 | 21,880,716.91 |
| 税金及附加 | 295,607.19 | 1,451,274.68 | 1,212,448.88 | 799,430.34 |
| 销售费用 | 12,430,941.99 | 51,933,890.07 | 34,818,725.83 | 23,228,529.46 |
| 管理费用 | 10,660,333.22 | 49,153,756.32 | 37,305,567.98 | 24,506,313.56 |
| 研发费用 | 13,318,794.2 | 49,922,930.62 | 33,757,447.63 | 22,415,456.03 |
| 财务费用 | -7,952,224.8 | -33,955,672.5 | -24,190,494.41 | -16,179,313.1 |
| 其中:利息费用 | 760,243.02 | 3,587,125.11 | 2,782,177.92 | 1,909,672.71 |
| 其中:利息收入 | 8,820,335.23 | 36,906,796.53 | 27,524,514.45 | 17,846,154.11 |
| 加:公允价值变动收益 | - | -1,804,926.16 | -1,804,926.16 | -1,804,926.16 |
| 加:投资收益 | 267,479.91 | 4,569,887.11 | 4,569,887.11 | 4,569,887.11 |
| 资产处置收益 | - | 141,603.68 | - | - |
| 资产减值损失(新) | -8,321,843.97 | -32,094,508.76 | -19,097,136.16 | -14,414,916.44 |
| 信用减值损失(新) | 57,960.39 | -2,448,524.63 | -3,525,505.81 | -2,970,046.26 |
| 其他收益 | 374,528.28 | 17,497,032.88 | 16,364,793.21 | 15,631,660.74 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -15,553,406.18 | -53,080,075.07 | -26,970,232.56 | -15,984,227.17 |
| 加:营业外收入 | 11,480.2 | 48,271.63 | 48,257.1 | 47,376.2 |
| 减:营业外支出 | 279,966.86 | 1,186,467.8 | 676,107.9 | 541,718.7 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -15,821,892.84 | -54,218,271.24 | -27,598,083.36 | -16,478,569.67 |
| 减:所得税费用 | -4,013,489.43 | 198,010.86 | -9,339,548.27 | -7,572,775.9 |
| 六、净利润 | -11,808,403.41 | -54,416,282.1 | -18,258,535.09 | -8,905,793.77 |
| 持续经营净利润 | -11,808,403.41 | -54,416,282.1 | -18,258,535.09 | -8,905,793.77 |
| 归属于母公司股东的净利润 | -11,808,403.41 | -54,416,282.1 | -18,258,535.09 | -8,905,793.77 |
| (一)基本每股收益 | -0.17 | -0.78 | -0.26 | -0.13 |
| (二)稀释每股收益 | -0.17 | -0.78 | -0.26 | -0.13 |
| 八、其他综合收益 | 21,986.91 | -23,123.4 | 6,228.41 | -2,068.23 |
| 归属于母公司股东的其他综合收益 | 21,986.91 | -23,123.4 | 6,228.41 | -2,068.23 |
| 九、综合收益总额 | -11,786,416.5 | -54,439,405.5 | -18,252,306.68 | -8,907,862 |
| 归属于母公司股东的综合收益总额 | -11,786,416.5 | -54,439,405.5 | -18,252,306.68 | -8,907,862 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |